Mark Ragosa
Chief Financial Officer at Kiniksa Pharmaceuticals International · 23 reported transactions in 1 company · latest trade Feb 9, 2026
Their trades
Sold | Feb 9, 2026 | Feb 9, 2026 close $44.35 → Oct 28, 2026 close $95.18. S&P 500 +10.9% over the same days. | ||
Sold | Feb 9, 2026 | Feb 9, 2026 close $44.35 → Oct 28, 2026 close $95.18. S&P 500 +10.9% over the same days. | ||
Sold | Jan 8, 2026 | Jan 8, 2026 close $41.73 → Oct 28, 2026 close $95.18. S&P 500 +11.6% over the same days. | ||
Sold | Dec 8, 2025 | Dec 8, 2025 close $41.55 → Oct 28, 2026 close $95.18. S&P 500 +12.6% over the same days. | ||
Sold | Nov 12, 2025 | Nov 12, 2025 close $40.58 → Oct 28, 2026 close $95.18. S&P 500 +12.6% over the same days. |
$381.7K
Feb 9, 2026 close $44.35 → Oct 28, 2026 close $95.18. S&P 500 +10.9% over the same days.
$390.5K
Feb 9, 2026 close $44.35 → Oct 28, 2026 close $95.18. S&P 500 +10.9% over the same days.
$502.7K
Jan 8, 2026 close $41.73 → Oct 28, 2026 close $95.18. S&P 500 +11.6% over the same days.
$1.78M
Dec 8, 2025 close $41.55 → Oct 28, 2026 close $95.18. S&P 500 +12.6% over the same days.
$814.7K
Nov 12, 2025 close $40.58 → Oct 28, 2026 close $95.18. S&P 500 +12.6% over the same days.